Eric Warren Esperion Therapeutics, Inc. (ESPR) insider trading activity

Eric Warren is Chief Commercial Officer of Esperion Therapeutics, Inc.. Currently has a direct ownership of 162,355 shares of ESPR, which is worth approximately $391,275. The most recent transaction as insider was on Nov 19, 2024, when has been sold 197 shares (Common Stock) at a price of $2.17 per share, resulting in proceeds of $427. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 162K

1.76% 3M change

137.65% 12M change

Total Value Held $391,275

Eric Warren Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Nov 19 2024	SELL Open market or private sale	$427 $2.17 p/Share	197 Reduced 0.12%	162,355 Common Stock
Oct 17 2024	SELL Open market or private sale	$226 $2.12 p/Share	107 Reduced 0.07%	162,552 Common Stock
Sep 17 2024	SELL Open market or private sale	$4,642 $1.78 p/Share	2,608 Reduced 1.58%	162,659 Common Stock
Aug 19 2024	SELL Open market or private sale	$411 $1.95 p/Share	211 Reduced 0.13%	165,267 Common Stock
Jul 17 2024	SELL Open market or private sale	$279 $2.59 p/Share	108 Reduced 0.07%	165,478 Common Stock
Jun 18 2024	SELL Open market or private sale	$7,264 $2.86 p/Share	2,540 Reduced 1.51%	165,586 Common Stock
May 17 2024	SELL Open market or private sale	$476 $2.48 p/Share	192 Reduced 0.11%	168,126 Common Stock
Mar 14 2024	BUY Grant, award, or other acquisition	-	100,000 Added 37.27%	168,318 Common Stock
Sep 20 2023	SELL Open market or private sale	$927 $1.25 p/Share	742 Reduced 1.07%	68,318 Common Stock
Aug 18 2023	SELL Open market or private sale	$342 $1.41 p/Share	243 Reduced 0.35%	69,060 Common Stock
Jul 19 2023	SELL Open market or private sale	$167 $1.58 p/Share	106 Reduced 0.15%	69,303 Common Stock
Jun 21 2023	SELL Open market or private sale	$892 $1.48 p/Share	603 Reduced 0.86%	69,409 Common Stock
May 17 2023	SELL Open market or private sale	$354 $1.62 p/Share	219 Reduced 0.31%	70,012 Common Stock
Apr 19 2023	SELL Open market or private sale	$147 $1.28 p/Share	115 Reduced 0.16%	70,231 Common Stock
Mar 17 2023	SELL Open market or private sale	$936 $1.78 p/Share	526 Reduced 0.74%	70,346 Common Stock
Mar 14 2023	BUY Grant, award, or other acquisition	-	22,300 Added 23.93%	70,872 Common Stock
Mar 07 2023	SELL Open market or private sale	$25,704 $5.05 p/Share	5,090 Reduced 9.49%	48,572 Common Stock
Oct 18 2022	SELL Open market or private sale	$823 $7.69 p/Share	107 Reduced 0.2%	53,662 Common Stock
Sep 19 2022	SELL Open market or private sale	$1,765 $6.92 p/Share	255 Reduced 0.47%	53,769 Common Stock
Aug 31 2022	BUY Open market or private purchase	$7,460 $7.46 p/Share	1,000 Added 1.82%	54,024 Common Stock
Aug 17 2022	SELL Open market or private sale	$1,357 $6.82 p/Share	199 Reduced 0.37%	53,024 Common Stock
Jul 19 2022	SELL Open market or private sale	$2,836 $6.58 p/Share	431 Reduced 0.8%	53,223 Common Stock
Jun 17 2022	SELL Open market or private sale	$1,254 $4.9 p/Share	256 Reduced 0.47%	53,654 Common Stock
May 17 2022	SELL Open market or private sale	$1,172 $5.98 p/Share	196 Reduced 0.36%	53,910 Common Stock
Mar 14 2022	BUY Grant, award, or other acquisition	-	13,000 Added 19.37%	54,106 Common Stock

Eric Warren

Chief Commercial Officer

Ann Arbor, MI

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ESPR shares.

Notify only if

Value

Insider Trading

Get notified when an Esperion Therapeutics, Inc. insider buys or sells ESPR shares.

Notify only if

Operation

Value

Type

News

Receive news related to Esperion Therapeutics, Inc.

Track Activities on ESPR

Account